Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SABA/SAMA/ICS vs LABA/LAMA/ICS in frequent exacerbator COPD
NCT05748977Phase 1Unknown
- Sponsor
- Assiut University
- Start
- Feb 2023
- Primary completion
- Feb 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised trial of fenoterol, ipratropium bromide, beclomethasone, salmeterol, tiotropium and 1 more in chronic obstructive pulmonary disease (COPD), sponsored by Assiut University. Primary endpoint: Dyspnea Score at 1 year. Status: unknown.
02
Drugs
fenoterolipratropium bromidebeclomethasonesalmeteroltiotropium
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT05748977.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05748977.